NUP214 and Alzheimer disease: Given that AD pathology is known to dysregulate autophagic pathways, and based on our previous observations that CaN inhibition can reinitiate autophagy, we sought to assess whether TAC treatment at the sub-immunosuppressive dose modulates key markers of this degradation process [7,25].